STARTING in 2024, the NSW Government's pharmacy prescribing trial expands access to prescription medicines for specific skin conditions. Participating pharmacists can provide certain medications without a prescription after a consultation. The trial aims to ease the burden on general practitioners. From late March, pending ethics approval, impetigo and shingles treatments will be included. The initiative, which began with urinary tract infection treatment, has expanded to over 1,100 pharmacies. The skin condition treatment segment of the trial will run for 12 months, benefiting patients and improving timely access to care. More details are available on the NSW Health website.
PHARMACY PRESCRIBING TRIAL EXPANDS TO SKIN
editor
Publisher
Michael Walls
michael@accessnews.com.au
0407 783 413